98 related articles for article (PubMed ID: 20804342)
1. An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis.
Xie F; Hu Y; Magee LA; Money DM; Patrick DM; Krajden M; Thomas E; von Dadelszen P;
Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1162-7. PubMed ID: 20804342
[TBL] [Abstract][Full Text] [Related]
2. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia.
von Dadelszen P; Magee LA; Krajden M; Alasaly K; Popovska V; Devarakonda RM; Money DM; Patrick DM; Brunham RC
BJOG; 2003 Aug; 110(8):725-30. PubMed ID: 12892683
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus antibody status at 17-18 weeks of gestation and pre-eclampsia: a case-control study of pregnant women in Norway.
Strand KM; Odland ML; Iversen AC; Nordbø SA; Vik T; Austgulen R
BJOG; 2012 Oct; 119(11):1316-23. PubMed ID: 22804776
[TBL] [Abstract][Full Text] [Related]
4. Adverse reproductive outcomes in urban women with adeno-associated virus-2 infections in early pregnancy.
Arechavaleta-Velasco F; Gomez L; Ma Y; Zhao J; McGrath CM; Sammel MD; Nelson DB; Parry S
Hum Reprod; 2008 Jan; 23(1):29-36. PubMed ID: 17977863
[TBL] [Abstract][Full Text] [Related]
5. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.
Eskild A; Jenum PA; Bruu AL
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1035-41. PubMed ID: 16232169
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
7. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction.
Goswami D; Tannetta DS; Magee LA; Fuchisawa A; Redman CW; Sargent IL; von Dadelszen P
Placenta; 2006 Jan; 27(1):56-61. PubMed ID: 16310038
[TBL] [Abstract][Full Text] [Related]
8. Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia.
Goulis DG; Chappell L; Gibbs RG; Williams D; Dave JR; Taylor P; de Swiet M; Poston L; Williamson C
BJOG; 2005 Mar; 112(3):299-305. PubMed ID: 15713143
[TBL] [Abstract][Full Text] [Related]
9. An evidence against the effect of chronic cytomegalovirus infection in unstable angina pectoris.
Alavi SM; Adel SM; Rajabzadeh AR
Acta Med Iran; 2011; 49(2):78-80. PubMed ID: 21598213
[TBL] [Abstract][Full Text] [Related]
10. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection.
Nigro G; Anceschi MM; Cosmi EV;
BJOG; 2003 Jun; 110(6):572-7. PubMed ID: 12798474
[TBL] [Abstract][Full Text] [Related]
12. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran.
Tabatabaee M; Tayyebi D
J Matern Fetal Neonatal Med; 2009 Jun; 22(6):517-21. PubMed ID: 19350446
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of cytomegalovirus, Chlamydia pneumoniae and herpes simplex virus type 2 infections with preeclampsia].
Zhang JF; Zhang WY
Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1413-5. PubMed ID: 22883201
[TBL] [Abstract][Full Text] [Related]
15. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
16. Trace elements and cytokine profile in cytomegalovirus-infected pregnancies: a controlled study.
Zhang JP; Li F; Yu XW; Sheng Q; Shi XW; Zhang XW
Gynecol Obstet Invest; 2008; 65(2):128-32. PubMed ID: 17957100
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to cytomegalovirus in a parturient population in Israel.
Stein O; Sheinberg B; Schiff E; Mashiach S; Seidman DS
Isr J Med Sci; 1997 Jan; 33(1):53-8. PubMed ID: 9203519
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
19. High perinatal seroprevalence of cytomegalovirus in northern Taiwan.
Chen MH; Chen PC; Jeng SF; Hsieh CJ; Su FC; Liao HF; Su YN; Lin SJ; Hsieh WS
J Paediatr Child Health; 2008 Apr; 44(4):166-9. PubMed ID: 17854407
[TBL] [Abstract][Full Text] [Related]
20. The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis.
Biri A; Bozdayi G; Ciçfti B; Dinç B; Yücel A; Rota S
Arch Gynecol Obstet; 2006 Feb; 273(5):261-6. PubMed ID: 16001197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
